Bioverativ Therapeutics Inc. drugs

4 results

  • alprolix

    (Coagulation Factor Ix (Recombinant), Fc Fusion Protein)
    Bioverativ Therapeutics Inc.
    ALPROLIX is a recombinant Factor IX concentrate for adults and children with hemophilia B (congenital Factor IX deficiency). Indicated for on-demand treatment of bleeding episodes, perioperative bleeding management, and routine prophylaxis to reduce bleeding frequency.
    Medication Details
    Drug Interactions

  • altuviiio - antihemophilic factor

    (Antihemophilic Factor (Recombinant), Fc-Vwf-Xten Fusion Protein-Ehtl)
    Bioverativ Therapeutics Inc.
    ALTUVIIIO is indicated for adults and pediatric patients with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce bleeding episodes, on-demand treatment and control of bleeding, and perioperative bleeding management. Not indicated for von Willebrand disease.
    Medication Details

  • eloctate

    (Antihemophilic Factor (Recombinant), Fc Fusion Protein)
    Bioverativ Therapeutics Inc.
    Eloctate is indicated for adults and children with Hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative bleeding management, and routine prophylaxis to reduce bleeding frequency. Not indicated for von Willebrand disease.
    Medication Details